miglustat has been researched along with Nervous System Diseases in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (42.86) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Brassier, A; Broué, P; Cances, C; Chabrol, B; Dahmani-Rabehi, B; Eyer, D; Freihuber, C; Héron, B; Labarthe, F; Latour, P; Levade, T; Pichard, S; Sevin, C; Vanier, MT | 1 |
| Bembi, B; Hollak, CE; Hughes, D; Schwierin, B; van Schaik, IN | 1 |
| Coll, MJ; de la Barca, OB; Domingo, R; Fumero, LM; Gaspar, A; Macías-Vidal, J; O'Callaghan, M; Peñas, JJ; Pérez, AV; Perez-Poyato, MS; Pineda, M; Pocovi, M; Portal, LR; Roldán, S; Silva, MT; Temudo, T; Vilaseca, MA | 1 |
| Chien, YH; Huang, AC; Hwu, WL; Lee, NC; Peng, SF; Su, SC; Tsai, LK; Tseng, CC; Yang, CC | 1 |
| Aryani, O; Ashrafi, MR; Ghofrani, M; Houshmand, M; Karimzadeh, P; Rahmanifar, A; Rezayi, A; Salehpour, S; Shafeghati, Y; Shiva, F; Shoar, BN; Taghdiri, MM; Tavasoli, A; Tonekaboni, SH; Zaman, T | 1 |
| Groot-Loonen, JJ; Hoogerbrugge, PM; Jacobs, JF; Wevers, RA; Willemsen, MA | 1 |
| Alfonso, P; Capablo, JL; de Cabezón, AS; Franco, R; Giraldo, P; Pocovi, M | 1 |
7 other study(ies) available for miglustat and Nervous System Diseases
| Article | Year |
|---|---|
Effects of miglustat therapy on neurological disorder and survival in early-infantile Niemann-Pick disease type C: a national French retrospective study.
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Child; Child, Preschool; Female; Humans; Infant; Nervous System Diseases; Niemann-Pick Disease, Type C; Pregnancy; Retrospective Studies; Young Adult | 2023 |
Miglustat (Zavesca) in type 1 Gaucher disease: 5-year results of a post-authorisation safety surveillance programme.
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Aged; Child; Child, Preschool; Enzyme Inhibitors; Europe; Female; Gaucher Disease; Humans; Male; Middle Aged; Nervous System Diseases; Retrospective Studies; Severity of Illness Index; Young Adult | 2009 |
Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series.
Topics: 1-Deoxynojirimycin; Adolescent; Adult; Age Factors; Child; Child, Preschool; Cognition; Female; Humans; Male; Nervous System Diseases; Niemann-Pick Disease, Type C | 2010 |
Long-term efficacy of miglustat in paediatric patients with Niemann-Pick disease type C.
Topics: 1-Deoxynojirimycin; Child; Child, Preschool; Cognition; Deglutition; Disease Progression; Drug Administration Schedule; Female; Humans; Male; Nervous System Diseases; Niemann-Pick Disease, Type C; Time; Treatment Outcome | 2013 |
Effects of miglustat on stabilization of neurological disorder in niemann-pick disease type C: Iranian pediatric case series.
Topics: 1-Deoxynojirimycin; Adolescent; Child; Child, Preschool; Enzyme Inhibitors; Female; Humans; Infant; Iran; Male; Nervous System Diseases; Niemann-Pick Disease, Type C; Retrospective Studies; Treatment Outcome; Young Adult | 2013 |
Allogeneic BMT followed by substrate reduction therapy in a child with subacute Tay-Sachs disease.
Topics: 1-Deoxynojirimycin; Bone Marrow Transplantation; Child; Female; Humans; Nervous System Diseases; Tay-Sachs Disease; Transplantation, Homologous | 2005 |
Neurologic improvement in a type 3 Gaucher disease patient treated with imiglucerase/miglustat combination.
Topics: 1-Deoxynojirimycin; Adult; Comorbidity; Disease Progression; Drug Administration Schedule; Drug Therapy, Combination; Dystonia; Electroencephalography; Enzyme Inhibitors; Epilepsies, Myoclonic; Gaucher Disease; Glucosylceramidase; Humans; Male; Nervous System Diseases; Recombinant Proteins; Syndrome; Treatment Outcome | 2007 |